Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals

Virology Journal

Volumn 10, Issue 1, 2013, Pages

  Mota Miranda, Aline C A ^a,b,c   Barreto, Fernanda K ^a   Amarante, Maria F C ^d   Batista, Everton ^a   Monteiro Cunha, Joana P ^b,c   Farre, Lourdes ^a   Galvão Castro, Bernardo ^a,b   Alcantara, Luiz C J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gp46; HAM TSP; HTLV 1; Mutation

Indexed keywords

AMINO ACID; DNA; EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN GP 46; HLA ANTIGEN CLASS 1; UNCLASSIFIED DRUG; GP46 PROTEIN, HUMAN T CELL LEUKEMIA VIRUS TYPE I; GP46 PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; ONCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DNA EXTRACTION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GLYCOSYLATION; HEREDITY; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; HYDROPHILICITY; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; T LYMPHOCYTE; TROPICAL SPASTIC PARAPARESIS; VIRUS LOAD; ADULT; AGED; AMINO ACID SEQUENCE; CHEMISTRY; FEMALE; GENETICS; HETEROZYGOTE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MUTATION; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ADULT; AGED; AMINO ACID SEQUENCE; CARRIER STATE; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE PRODUCTS, ENV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PARAPARESIS, TROPICAL SPASTIC; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE PROTEINS, ONCOGENIC;

EID: 84883139451     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-75     Document Type: Article

References (44)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419.
2. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, 1:1031-1032.
3. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares B, Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, De The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
5. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS: The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990, 3:1096-1101.
6. Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A: Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17:167-170.
7. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Has Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 4:586-593.
8. Grassi MFR, Olavarria VN, Kruschewsky RA, Mascarenhas E, Dourado I, Correia LCL, Castro-Costa CM, Galvão-Castro B: Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to New diagnostic criteria of HAM/TSP. J Medical Virology 2011, 83:1269-1274.
9. Jeffery KJM, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999, 96:3848-3853.
10. Jeffery KJM, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AV, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CRM: The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunology 2000, 165:7278-7284.
11. Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, Kubota T, Yamashita R, Tachibana N, Tsubouchi H, Mueller N: Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr 1994, 7:199-203.
12. Lal RB, Giam CZ, Coligan JE, Rudolph DL: Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy. J Infectious Diseases 1994, 169:496-503.
13. Iniguez AM, Otsuki K, Magalhães GP, Silva EA, Vicente ACP: Genetic markers on the HTLV-1 p12I protein sequences from Brazilian HAM/TSP patients and asymptomatic HTLV-1 carrier isolates. AIDS Res Human Retroviruses 2005, 21(6):580-582.
14. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003, 115:449-459.
15. Ghez D, Lepelletier Y, Lambert S, Fourneau JM, Blot V, Janvier S, Arnulf B, van Endert PM, Heveker N, Pique C: Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J Virol 2006, 80:6844-6854.
16. Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW: Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol 2005, 79:12692-12702.
17. Seki M, Sashiyama H, Hayami M, Shida H: Intracellular processing and immunogenicity of the envelope proteins of human T-cell leukemia virus type I that are expressed from recombinant vaccinia viruses. Virus genes 1990, 3:235-249.
18. Sagara Y, Inoue Y, Shiraki H, Jinno A, Hoshino H, Maeda Y: Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. J Virol 1996, 70(3):1564-1569.
19. Rosenberg A, Delamarre L, Preira A, Dokhelar MC: Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol 1998, 72(9):7609-7614.
20. Ilinskaya A, Heidecker G, Derse D: Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking. J Virol 2010, 84:6995-7004.
21. Bangham CRM: The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 2003, 84:3177-3189.
22. Kosako T, Akimoto M, Toji S, Tomohiro K, White Y, Suzuki S, Arima T, Suruga Y, Matsushita K, Shimeno H, Soeda S, Kubota R, Izumo S, Uozumi K, Arima N: Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. J Med Virol 2011, 83:501-509.
23. Mota-Miranda AC, de Oliveira T, Moreau DR, Bomfim C, Galvão-Castro B, Alcântara LCJ: Mapping the molecular characteristics of Brazilian human T-cell lymphotropic virus type 1 Env (gp46) and Pol amino acid sequences for vaccine design. Mem Inst Oswaldo Cruz 2007, 102(6):741-749.
24. Kazanji M, Heraud JM, Merien F, Pique C, de The G, Gessain A, Jacobson S: Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). J Gen Virol 2006, 87:1331-1337.
25. Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O: Current concept regarding the HTLV-1 receptor complex. Retrovirology 2010, 7:99-110.
26. Kuo CS, Mirsaliotis A, Brighty DW: Antibodies to the envelope glycoprotein of human T cell leukemia virus type I robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process. J Immunology 2011, 187:361-371.
27. Shembade N, Harhaj ED: Role of post-translactional modifications of HTLV-1 Tax in NF-κB activation. World J Biol Chemist 2010, 26:13-20.
28. Kurtzke JF: A new scale for evaluating disability in multipli sclerosis. Neurology 1955, 5:580-583.
29. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, Plumelle Y, Smadja D, Nicolas JC: Quantification of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 2002, 102:37-51.
30. Jeanmougin F, Thompson JD, Goy M, Higgins DG, Gibson TJ: Multiple sequence alignment with clustal X. Trends Biochem Sci 1998, 23:403-405.
31. Nicholas KB, Nicholas HBJ, Deerfield DW: GeneDoc: analysis and visualization of genetic variation. Embnew News 1997, 4:14.
32. Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp Ser 1999, 41:95-98.
33. Kumar S, Tamura K, Nei M: MEGA: molecular evolutionary genetics analysis software for microcomputers. Cabios 1994, 10:189-191.
34. Yang Z, Nielsen R, Goldman N, Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000, 155:431-449.
35. Pond SLK, Muse SP: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2000, 21:676-679.
36. De Oliveira T, Salemi M, Gordon M, Vandamme AM, Van Rensburg EJ, Engelbrecht S, Coovadia HM, Cassol S: Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? Genetics 2004, 167:1047-1058.
37. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
38. Argos P, Rao JK, Hargrave PA: Structural prediction of membrane-bound proteins. Eur J Biochem 1982, 15:565-575.
39. Kyte J, Doolittle R: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132.
40. Hopp TP, Woods KR: Physico-chemical profiles: a computer program for predicting protein antigenic determinants. Mol Immunol 1983, 20:483-489.
41. Karplus PA, Schulz GE: Prediction of chain flexibility in proteins - a tool for the selection of peptide antigens. Naturwissenschafren 1985, 72:212-213.
42. Parker JMR, Guo D, Hodges RS: New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray -derived accessible sites. Biochemistry 1986, 25:5425-5431.
43. Queiroz AT, Mota-Miranda AC, De Oliveira T, Moreau DR, Urpia CDE, Carvalho CM, Galvão-Castro B, Alcantara LCJ: Re-mapping the molecular features of the human immunodeficiency virus type 1 and human T-cell lymphotropic virus type 1 Brazilian sequences using a bioinformatics unit established in Salvador, Bahia, Brazil, to give support to the viral epidemiology studies. Mem Inst Oswaldo Cruz 2007, 102:133-139.
44. Arnold K, Bordoli L, Kopp J, Schwede T: The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics 2006, 22:195-201.